期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 13, 期 7, 页码 737-748出版社
TAYLOR & FRANCIS AS
DOI: 10.1586/14737159.2013.835570
关键词
biofluid; lung cancer; metabolomics; metabonomics; MS; NMR; plasma; serum; urine
类别
资金
- European Regional Development Fund through the Competitive Factors Thematic Operational Programme
- Foundation for Science and Technology (FCT), Portugal [PEst-C/CTM/LA0011/2013]
- FCT [SFRH/BD/63430/2009]
- FCT
The knowledge that the organism's metabolome is a potentially informative mirror of the impact of disease and its dynamics has led to promising developments in cancer research, strongly geared toward the discovery of new biomarkers of disease onset and progression. The present text reviews the advances made in the last 10 years in lung cancer research making use of the metabolomics strategies, particularly concerning metabolite profiling of human biofluids (blood serum and plasma, urine and others), expected to reflect the deviant metabolic behavior of lung tumors. The main goal of this article is to provide the reader with an up-to-date summary of the main metabolic variations taking place in biofluids, in relation to lung cancer, as well as of the analytical strategies employed to unveil them. Furthermore, particular needs and challenges are identified and possible developments envisaged.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据